K

Kazia Therapeutics Limited
D

KZIA

3.58000
USD
0.07
(1.99%)
مغلق
حجم التداول
198
الربح لكل سهم
-40
العائد الربحي
-
P/E
-0
حجم السوق
4,867,458
أصول ذات صلة
AZN
AZN
-0.110
(-0.16%)
70.410 USD
BMY
BMY
-0.140
(-0.30%)
46.870 USD
GSK
GSK
-0.560
(-1.43%)
38.690 USD
LLY
LLY
-7.85
(-1.09%)
713.61 USD
MRK
MRK
-0.220
(-0.28%)
77.600 USD
NVS
NVS
0.240
(0.21%)
112.750 USD
PFE
PFE
0.110
(0.47%)
23.330 USD
SNY
SNY
-0.515
(-0.98%)
51.995 USD
المزيد
الأخبار المقالات

العنوان: Kazia Therapeutics Limited

القطاع: Healthcare
الصناعة: Biotechnology
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.